ALXA

Alexza Pharmaceuticals, Inc. News Headlines

$2.27
*  
0.02
0.89%
Get ALXA Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading ALXA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Sector Update: Health Care Stocks Climbing; Alexza Pharmaceuticals, Teva Complete First-Time Stocking of Adusuve in U.S.
10/10/2014 1:08:24 PM - MT Newswires


Sector Update: Health Care
10/10/2014 1:00:41 PM - MT Newswires


Alexza Pharmaceuticals Q2 14 Earnings Conference Call At 5:00 PM ET
8/7/2014 3:03:00 PM - RTT News


ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results
8/1/2014 12:32:00 AM - RTT News


5 Stocks Under 10 Dollars With High Levels of Free Cash Flow
2/28/2014 11:23:00 AM - Kapitall


Teva To Price Alexza's New Drug Adasuve At $145 Per Dose In The U.S.
2/4/2014 1:17:00 PM - Seeking Alpha


Alexza Pharmaceuticals: Stage Set For Adasuve
8/25/2013 11:06:00 AM - Seeking Alpha


Alexza Expects 2nd Half Of 2013 And 2014 To Be Eventful
8/22/2013 8:07:00 AM - Seeking Alpha


Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What?
5/15/2013 8:29:00 AM - Seeking Alpha


Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning
5/15/2013 5:17:00 AM - Seeking Alpha


After-Hours Earnings Report for May 14, 2013 : A, EXP, VIPS, PLAB, VOXX, ATHX, FENG, ALXA, TKMR, PRMW, QBAK, TXCC
5/14/2013 2:00:05 PM - NASDAQ.com News


Teva - Alexza Sign Deal for Adasuve - Analyst Blog
5/13/2013 5:06:40 PM - Zacks.com


XenoPort: A High Probablity Run-Up Trade
4/18/2013 9:15:00 AM - Seeking Alpha


Companies That Can Mend The Biotech Market: Stephen Brozak
4/12/2013 5:40:00 PM - Seeking Alpha


3 Biotechs With Upcoming Product Launches
4/11/2013 10:28:00 AM - Seeking Alpha


Large trade positions for drop in Alexza
4/2/2013 1:08:00 PM - optionMONSTER


Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
3/24/2013 4:30:00 AM - Seeking Alpha


Why Alexza Pharmaceuticals Ran 10% In 5 Minutes
3/6/2013 9:17:00 AM - Seeking Alpha


MAP's Levadex Ready For FDA Approval
2/3/2013 3:55:00 AM - Seeking Alpha


FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
1/10/2013 11:08:00 AM - Seeking Alpha


Value Of Alexza's Staccato Platform Following Adasuve Approval
12/25/2012 5:11:00 AM - Seeking Alpha


Drug Approvals Are Priced In, Wait For The Buying Opportunity
12/24/2012 5:42:00 AM - Seeking Alpha


Alexza: Maybe A Little Speculation Is Warranted
12/20/2012 11:52:00 AM - Seeking Alpha


Roth Capital Expects FDA Approval For Alexza's Adasuve
12/20/2012 4:51:00 AM - Seeking Alpha


This Week's Biotech Summary (December 16-21, 2012)
12/19/2012 4:01:00 PM - Seeking Alpha